NCT05095922View on ClinicalTrials.gov

Effect of HMP on Diabetic Microangiopaemia in T2DM

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 28, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions
Diabetes Mellitus, Type 2Diabetic Angiopathies
Interventions
DRUG

Heart-Protecting Musk Pill

Heart-Protecting Musk Pill (pill, 45mg, three times a day, 3 months)

DRUG

Valsartan Capsules

Valsartan Capsules(capsule, 80mg, once a day, 3 months）

DRUG

Calcium Dobesilate Capsules

Calcium Dobesilate Capsules(capsule, 500mg, three times a day, 3 months)

Trial Locations (1)

226000

Affiliated Hospital of Nantong University, Nantong

All Listed Sponsors
lead

Affiliated Hospital of Nantong University

OTHER